» Articles » PMID: 36397729

Cancer Situation in China: What Does the China Cancer Map Indicate from the First National Death Survey to the Latest Cancer Registration?

Overview
Publisher Wiley
Specialty Oncology
Date 2022 Nov 18
PMID 36397729
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Over the past four decades, the Chinese government has conducted three surveys on the distribution of causes of death and built cancer registration. In order to shine a new light on better cancer prevention strategies in China, we evaluated the profile of cancer mortality over the forty years and analyzed the policies that have been implemented.

Methods: We described spatial and temporal changes in both cancer mortality and the ranking of major cancer types in China based on the data collected from three national surveys during 1973-1975, 1990-1992, 2004-2005, and the latest cancer registration data published by National Central Cancer Registry of China. The mortality data were compared after conversion to age-standardized mortality rates based on the world standard population (Segi's population). The geographical distribution characteristics were explored by marking hot spots of different cancers on the map of China.

Results: From 1973 to 2016, China witnessed an evident decrease in mortality rate of stomach, esophageal, and cervical cancer, while a gradual increase was recorded in lung, colorectal, and female breast cancer. A slight decrease of mortality rate has been observed in liver cancer since 2004. Lung and liver cancer, however, have become the top two leading causes of cancer death for the last twenty years. From the three national surveys, similar profiles of leading causes of cancer death were observed among both urban and rural areas. Lower mortality rates from esophageal and stomach cancer, however, have been demonstrated in urban than in rural areas. Rural areas had similar mortality rates of the five leading causes of cancer death with the small urban areas in 1973-1975. Additionally, rural areas in 2016 also had approximate mortality rates of the five leading causes with urban areas in 2004-2005. Moreover, stomach, esophageal, and liver cancer showed specific geographical distributions. Although mortality rates have decreased at most of the hotspots of these cancers, they were still higher than the national average levels during the same time periods.

Conclusions: Building up a strong primary public health system especially among rural areas may be one critical step to reduce cancer burden in China.

Citing Articles

The effectiveness of Evodia rutaecarpa hot compress on the recovery of gastrointestinal function after laparoscopic surgery for colorectal cancer: A propensity score-matched retrospective cohort study.

Huang M, Li J, Huang W, Zhou Y, Cai L, Liu M PLoS One. 2025; 20(2):e0303951.

PMID: 39977411 PMC: 11841865. DOI: 10.1371/journal.pone.0303951.


Level and clinical significance of serum CXC chemokine ligand 13 in patients with hepatocellular carcinoma.

Wu Y, Ran X, Li Q, Wu Y, Shen X, Mu M Transl Cancer Res. 2025; 14(1):424-433.

PMID: 39974413 PMC: 11833404. DOI: 10.21037/tcr-24-1306.


Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset.

Sun Y, Lin X, Zou Z, Zhou Y, Liu A, Li X Lipids Health Dis. 2025; 24(1):57.

PMID: 39966964 PMC: 11837645. DOI: 10.1186/s12944-025-02482-0.


Laparoscopic hepatectomy using indocyanine green attenuates postoperative inflammatory response for hepatocellular carcinoma: A propensity score matching analysis.

Wu W, Huang M, Wang M, Chen L, Hu B, Ding Z World J Gastrointest Surg. 2025; 17(1):101793.

PMID: 39872757 PMC: 11757202. DOI: 10.4240/wjgs.v17.i1.101793.


Global Burden of Esophageal Cancer and Its Risk Factors: A Systematic Analysis of the Global Burden of Disease Study 2019.

Ilic I, Zivanovic Macuzic I, Ravic-Nikolic A, Ilic M, Milicic V Life (Basel). 2025; 15(1).

PMID: 39859964 PMC: 11767048. DOI: 10.3390/life15010024.


References
1.
Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View

2.
Sumida Y, Yoneda M, Seko Y, Ishiba H, Hara T, Toyoda H . Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics (Basel). 2020; 10(8). PMC: 7459689. DOI: 10.3390/diagnostics10080579. View

3.
Gong Y, Wang Y, Yuan Y . Distribution of Helicobacter pylori in north China. World J Gastroenterol. 2005; 11(23):3523-7. PMC: 4315953. DOI: 10.3748/wjg.v11.i23.3523. View

4.
You W, Zhang L, Gail M, Chang Y, Liu W, Ma J . Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000; 92(19):1607-12. DOI: 10.1093/jnci/92.19.1607. View

5.
Li J, Liu B, Li G, Chen Z, Sun X, Rong S . Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research. Int J Epidemiol. 1981; 10(2):127-33. DOI: 10.1093/ije/10.2.127. View